GB1478020A - Composition for the treatment of asthma - Google Patents

Composition for the treatment of asthma

Info

Publication number
GB1478020A
GB1478020A GB4321873A GB4321873A GB1478020A GB 1478020 A GB1478020 A GB 1478020A GB 4321873 A GB4321873 A GB 4321873A GB 4321873 A GB4321873 A GB 4321873A GB 1478020 A GB1478020 A GB 1478020A
Authority
GB
United Kingdom
Prior art keywords
particles
treatment
active ingredient
asthma
sept
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB4321873A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Beecham Group PLC
Original Assignee
Beecham Group PLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beecham Group PLC filed Critical Beecham Group PLC
Priority to GB4321873A priority Critical patent/GB1478020A/en
Priority to FR7429814A priority patent/FR2243677B1/fr
Priority to BE148147A priority patent/BE819464A/en
Priority to AU73308/74A priority patent/AU7330874A/en
Priority to DE19742443891 priority patent/DE2443891A1/en
Priority to NL7412156A priority patent/NL7412156A/en
Priority to JP10660774A priority patent/JPS5076222A/ja
Publication of GB1478020A publication Critical patent/GB1478020A/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/007—Pulmonary tract; Aromatherapy
    • A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
    • A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Otolaryngology (AREA)
  • Pulmonology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

1478020 Treatment of asthma BEECHAM GROUP Ltd 2 Sept 1974 [14 Sept 1973] 43218/73 Addition to 1399460 Heading A5B Pharmaceutical compositions for administration by insufflation in the treatment of extrinsic asthma and hay fever in the form of a free-flowing powder comprising particles of 1-(3, 4-dihydroxy-phenyl)-2-isopropylamino-1- butanol or a pharmaceutically acceptable acid addition salt thereof as active ingredient substantially all (i.e. at least 85% by weight) of which particles of active ingredient have diameters in the range 0.01 to 10 microns and particles of at least one pharmaceutically acceptable non-hygroscopic solid carrier e.g. lactose, mannitol, substantially all of which carrier particles have diameters in the range 30 to 100 microns. The active ingredient is preferably the 1-erythro isomer and a preferred acid addition salt is the methane sulphonate.
GB4321873A 1973-09-14 1973-09-14 Composition for the treatment of asthma Expired GB1478020A (en)

Priority Applications (7)

Application Number Priority Date Filing Date Title
GB4321873A GB1478020A (en) 1973-09-14 1973-09-14 Composition for the treatment of asthma
FR7429814A FR2243677B1 (en) 1973-09-14 1974-09-02
BE148147A BE819464A (en) 1973-09-14 1974-09-02 PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF ASTHMA
AU73308/74A AU7330874A (en) 1973-09-14 1974-09-13 Treatment of asthma
DE19742443891 DE2443891A1 (en) 1973-09-14 1974-09-13 MEDICINAL PREPARATIONS FOR INSUFFLATION
NL7412156A NL7412156A (en) 1973-09-14 1974-09-13 METHOD FOR PREPARING A PHARMACEUTICAL PREPARATION FOR THE TREATMENT OF ASTHMATIC DISORDERS.
JP10660774A JPS5076222A (en) 1973-09-14 1974-09-14

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB4321873A GB1478020A (en) 1973-09-14 1973-09-14 Composition for the treatment of asthma

Publications (1)

Publication Number Publication Date
GB1478020A true GB1478020A (en) 1977-06-29

Family

ID=10427787

Family Applications (1)

Application Number Title Priority Date Filing Date
GB4321873A Expired GB1478020A (en) 1973-09-14 1973-09-14 Composition for the treatment of asthma

Country Status (7)

Country Link
JP (1) JPS5076222A (en)
AU (1) AU7330874A (en)
BE (1) BE819464A (en)
DE (1) DE2443891A1 (en)
FR (1) FR2243677B1 (en)
GB (1) GB1478020A (en)
NL (1) NL7412156A (en)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183782B1 (en) 1994-03-15 2001-02-06 Glaxo Group Limited Inhalation composition containing lactose pellets

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6183782B1 (en) 1994-03-15 2001-02-06 Glaxo Group Limited Inhalation composition containing lactose pellets
US6955824B1 (en) 1994-03-15 2005-10-18 Glaxo Group Limited Inhalation composition containing lactose pellets

Also Published As

Publication number Publication date
DE2443891A1 (en) 1975-03-27
FR2243677B1 (en) 1978-07-21
NL7412156A (en) 1975-03-18
AU7330874A (en) 1976-03-18
FR2243677A1 (en) 1975-04-11
BE819464A (en) 1975-03-03
JPS5076222A (en) 1975-06-21

Similar Documents

Publication Publication Date Title
IE45256L (en) Quinazolone derivatives
EP0221041A3 (en) Benzimidazole derivatives, process for their preparation and their pharmaceutical use
GB1298771A (en) Carboxylic esters of hydroxyphenylalkanolamines
HUT67661A (en) New pyrazine derivatives, their preparation and pharmaceutical compositions containing them
GB1418208A (en) Pharmaceutical compositions
ES8207124A1 (en) Secondary amines, their preparation and use in pharmaceutical compositions.
GB1298494A (en) Phenylethanolamine derivatives
IL42513A (en) N-(1h-tetrazol-5-yl)-quinaldamide derivatives,their production and pharmaceutical compositions containing them
ATE69228T1 (en) AMIDA COMBINATIONS.
GB1487334A (en) Pharmaceutical preparations comprising lisuride and/or physiologically tolerable salts thereof
IL47937A (en) Pharmaceutical compositions containing 6,8-diethyl-5-hydroxy-4-oxo-4h-1-benzopyran-2-carboxylic acid or a salt thereof
ES8800235A1 (en) Syn-isomer of 7-substituted-3-vinyl-3-cephem compounds, processes for production thereof and pharmaceutical compositions containing them.
ES8308833A1 (en) Novel 3-phenyl-1-indanamines, pharmaceutical compositions and methods of preparation.
GB1478020A (en) Composition for the treatment of asthma
ES471993A1 (en) Derivatives of pentacyclic alcaloids, method for their preparation, application in the synthesis of products of the eburnamonine group and pharmaceutical compositions.
GB1363047A (en) Pyrimidine derivative process for its preparation and its use as a medicament
GB1231250A (en)
GB1359044A (en) Quinoline derivatives
MY100752A (en) Pharmaceutical composition for combating malaria.
GB1399460A (en) Composition for the treatment of asthma
GB1509778A (en) Pharmaceutical composition and dosage units thereof
IE35492B1 (en) 2-benzylphenols their preparation and compositions containing them
ES342394A1 (en) Novel Benzylaminoimidazoline Derivatives, the preparation thereof and Compositions containing the same
GB1375806A (en)
GB1220793A (en) Pharmaceutical compositions

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee